Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials
NHS hospitals in England used £33,765,396 of indicative cost of Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 5.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £2,855,700 |
| The Christie Nhs Foundation Trust | £2,026,044 |
| Southend Univ Hosp Nhs Foundation Trust | £943,884 |
| Univ Hpl B/Ham Nhs Foundation Trust | £811,620 |
| Barts Health Nhs Trust | £799,596 |
| The Royal Marsden Nhs Foundation Trust | £757,512 |
| Nottingham University Hospitals Trust | £727,452 |
| Sheffield Teaching Hospitals Nhs Trust | £715,428 |
| University Hpls Of Leicester Nhs Trust | £607,212 |
| United Lincolnshire Hospitals Nhs Trust | £571,140 |
The primary-care picture
Pertuzumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Pertuzumab medicine page.